U.S. Insomnia Therapies Markets

U.S. Insomnia Therapies Markets

 

RELEASE DATE
16-Apr-2004
REGION
North America
Research Code: A747-01-00-00-00
SKU: HC00961-NA-MR_04816
AvailableYesPDF Download

$2,450.00

Special Price $1,837.50 save 25 %

In stock
SKU
HC00961-NA-MR_04816

$2,450.00

$1,837.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research service analyzes the changing dynamics within the U.S. insomnia therapies market. Included in this research service are revenue forecasts, market shares, patient forecasts, market and technology trends, factors affecting market growth, major issues and challenges, pricing trends, and product analysis. The market is segmented by product class - benzodiazepines, sedating antidepressants, non-benzodiazepines, and emerging therapies. This research service discusses the current and future market landscape, critically evaluates each major product, and highlights the window of opportunities in this fledgling market.

Table of Contents

Executive Summary

  • Executive Summary

Overview

  • Scope and Segmentation
  • Research Methodology
  • Introduction
  • Market and Technology Trends

Market Dynamics

  • Demand Analysis
  • Patient Forecasts
  • Revenue Forecasts
  • Industry Issues and Challenges

Competitive Landscape

  • Competitive Structure
  • Pipeline Analysis
  • Market Share Analysis

Frost & Sullivan Awards

  • Product Value Enhancement of the Year Award
  • Specialty Product of the Year Award
  • Industry Innovation and Advancement of the Year Award
  • Company of the Year Award

Segment Highlights

Overview

Market Forecasts and Trends

Competitive Analysis

  • Segment Highlights

Segment Highlights

Overview

Market Forecasts and Trends

Competitive Analysis

Segment Highlights

Overview

Market Forecasts and Trends

Competitive Analysis

Segment Highlights

Overview

Market Forecasts and Trends

Related Research
This research service analyzes the changing dynamics within the U.S. insomnia therapies market. Included in this research service are revenue forecasts, market shares, patient forecasts, market and technology trends, factors affecting market growth, major issues and challenges, pricing trends, and product analysis. The market is segmented by product class - benzodiazepines, sedating antidepressants, non-benzodiazepines, and emerging therapies. This research service discusses the current and future market landscape, critically evaluates each major product, and highlights the window of opportunities in this fledgling market.
More Information
No Index Yes
Podcast No
Industries Healthcare
WIP Number A747-01-00-00-00
Is Prebook No